LAKE
FOREST, Calif., June 2, 2022
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, announced today that it will be presenting at the
2022 LD Micro Invitational, a prominent three-day investor
conference, at the Four Seasons Hotel Westlake Village on
Wednesday, June 8, 2022 at
3:30 PM PST / 6:30 PM EST. President and Chief Executive
Officer, John Beaver, will be
presenting to a live and virtual audience.
Register to watch the event here:
https://ldinv12.mysequire.com/
The LD Micro Invitational will take place June 7-9, 2022 and will be available virtually on
the Sequire Virtual Events platform.
View BIOLASE's profile
here: http://www.ldmicro.com/profile/BIOL
About BIOLASE
BIOLASE is a medical device company that develops,
manufactures, markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals. BIOLASE's
proprietary laser products incorporate approximately 301 patented
and 32 patent-pending technologies designed to provide biologically
and clinically superior performance with less pain and faster
recovery times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 43,300 laser systems
to date in over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information
on Waterlase iPlus®, Waterlase Express™,
and laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and
LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®,
Waterlase® and Waterlase iPlus® are
registered trademarks of BIOLASE, Inc.
For further information, please contact:
Investors:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-to-present-at-ld-micro-invitational-investor-conference-on-june-8-2022-301559852.html
SOURCE BIOLASE, Inc.